$68.00
0.25[0.37%]
At close: Apr 15
$68.00
0[0.00%]
PreMarket: 7:59PM EDT
Gilead Sciences
(NASDAQ:GILD)Overview Rating
Good
Gilead Sciences Stock (NASDAQ:GILD), Quotes and News Summary
Gilead Sciences Stock (NASDAQ: GILD) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 7.389M |
| Day Range | - - - |
| 52 Wk Range | 67.620 - 87.865 |
| Market Cap | $84.794B |
| P/E Ratio | 15.056 |
| Dividend Yield | 4.550% |
| Exchange | NASDAQ |
| RSI | 30 |
| Short Interest | 1.81% |
| Days to Cover | 3.23 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Gilead Sciences, Inc.
Sector
Health Care
Industry
Biotechnology
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with t...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Gilead Sciences (GILD) stock?
You can purchase shares of Gilead Sciences (NASDAQ: GILD) through any online brokerage.
Who are Gilead Sciences's (GILD) competitors?
Other companies in Gilead Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Gilead Sciences (GILD) stock?
The latest price target for Gilead Sciences (NASDAQ: GILD) was reported by Wells Fargo on Monday, March 4, 2024. The analyst firm set a price target for 78.00 expecting GILD to rise to within 12 months (a possible 14.71% upside). 29 analyst firms have reported ratings in the last year.
Current Stock Price for Gilead Sciences (GILD)?
The stock price for Gilead Sciences (NASDAQ: GILD) is $68 last updated April 15, 2024 at 7:59 PM EDT.
Does Gilead Sciences (GILD) pay a dividend?
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on March 28, 2024 to stockholders of record on March 14, 2024.
When is Gilead Sciences (NASDAQ:GILD) reporting earnings?
Gilead Sciences’s Q1 earnings are confirmed for Thursday, April 25, 2024.
Is Gilead Sciences (GILD) going to split?
There is no upcoming split for Gilead Sciences.
What sector and industry does Gilead Sciences (GILD) operate in?
Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.